About Us
Company Overview
Established in 2006, Genolution Inc. has been providing solutions toward a better life by focusing on the fields of molecular diagnostics and RNAi. Our core technologies to develop faster, more affordable, and higher through-put nucleic acid extraction platforms led to the development of the Nextractor® nucleic acid extraction instrument series and extraction kits; they were vital for our progress in the fields of molecular diagnostics, genetic testing, and life sciences research. Moreover, our double-stranded RNA (dsRNA) synthesis technology enabled us to equip researchers with large-scale dsRNA for gene expression studies and pest control product development.
![](https://genolution.co.kr/wp-content/uploads/2023/12/img_companyLogo.png)
![](https://genolution.co.kr/wp-content/uploads/2023/12/img_corp_2.png)
Key Excutives
Genolution is operated by a team of individuals with different expertise to bring solutions toward a better life.
![](https://genolution.co.kr/wp-content/uploads/2024/03/img_team_ceo2.png)
Giok, KIM
CEO
• CEO, Hoilbiomed
• B.A. in History, Korea University
![](https://genolution.co.kr/wp-content/uploads/2024/03/img_team_cto2.png)
Minlee Kim, Ph.D
CTO
• Senior Scientist, Samsung Bioepis
• Researcher, Beth Israel Deaconess Medical Center
• Ph.D. in Molecular, Cellular Developmental Biology, Yale University
![](https://genolution.co.kr/wp-content/uploads/2024/03/img_team_cfo2.png)
Sanghoon Kim
CFO
• MA in Accounting, Dongguk University
• Director of Finance and Operation, Medtronic Korea